Jacobs Levy Equity Management’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-6,760
Closed -$645K 1154
2021
Q2
$645K Sell
6,760
-5,696
-46% -$543K ﹤0.01% 820
2021
Q1
$1.21M Buy
12,456
+3,460
+38% +$337K 0.01% 696
2020
Q4
$745K Buy
8,996
+1,619
+22% +$134K 0.01% 787
2020
Q3
$456K Buy
7,377
+6,213
+534% +$384K ﹤0.01% 812
2020
Q2
$103K Hold
1,164
﹤0.01% 1003
2020
Q1
$130K Sell
1,164
-8,951
-88% -$1,000K ﹤0.01% 940
2019
Q4
$2.48M Buy
10,115
+1,881
+23% +$460K 0.02% 505
2019
Q3
$2.84M Buy
8,234
+3,548
+76% +$1.22M 0.03% 441
2019
Q2
$4.31M Sell
4,686
-626
-12% -$576K 0.06% 377
2019
Q1
$8.47M Buy
5,312
+1,294
+32% +$2.06M 0.12% 218
2018
Q4
$7.51M Buy
4,018
+245
+6% +$458K 0.13% 176
2018
Q3
$8.9M Buy
3,773
+695
+23% +$1.64M 0.13% 192
2018
Q2
$10.6M Buy
3,078
+31
+1% +$107K 0.17% 175
2018
Q1
$8.65M Buy
3,047
+55
+2% +$156K 0.14% 199
2017
Q4
$7.7M Buy
2,992
+440
+17% +$1.13M 0.14% 208
2017
Q3
$7.24M Sell
2,552
-26
-1% -$73.8K 0.14% 207
2017
Q2
$6.1M Buy
2,578
+426
+20% +$1.01M 0.13% 205
2017
Q1
$5.42M Buy
2,152
+337
+19% +$849K 0.11% 235
2016
Q4
$4.09M Buy
1,815
+1,307
+257% +$2.95M 0.08% 282
2016
Q3
$1.27M Sell
508
-16
-3% -$40.1K 0.02% 521
2016
Q2
$1.6M Sell
524
-266
-34% -$814K 0.03% 472
2016
Q1
$2.51M Buy
+790
New +$2.51M 0.05% 356
2015
Q4
Sell
-425
Closed -$1.35M 891
2015
Q3
$1.35M Sell
425
-11
-3% -$35K 0.03% 431
2015
Q2
$1.74M Sell
436
-127
-23% -$508K 0.03% 398
2015
Q1
$2.25M Buy
563
+490
+671% +$1.96M 0.04% 350
2014
Q4
$359K Sell
73
-6
-8% -$29.5K 0.01% 649
2014
Q3
$322K Sell
79
-137
-63% -$558K 0.01% 667
2014
Q2
$872K Buy
+216
New +$872K 0.01% 541